ReviewLife (Basel, Switzerland)2022

The Impact of 52-Week Single Inhaler Device Triple Therapy versus Dual Therapy on the Mortality of COPD Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Chih-Cheng Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.